Xtant Medical Inc. (XTNT)

AMEX: XTNT · Real-Time Price · USD

0.47

-0.04 (-7.50%)

At close: May 01, 2025, 3:59 PM

0.52

11.28%

After-hours: May 01, 2025, 07:26 PM EDT

-7.50% (1D)

Bid	0.45
Market Cap	64.99M
Revenue (ttm)	117.27M
Net Income (ttm)	-16.45M
EPS (ttm)	-0.12
PE Ratio (ttm)	-3.89
Forward PE	-26.32
Analyst	Strong Buy

Ask	0.52
Volume	102,080
Avg. Volume (20D)	91,926
Open	0.51
Previous Close	0.51
Day's Range	0.46 - 0.51
52-Week Range	0.33 - 0.96
Beta	-0.04

About XTNT

Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect ...

[Read more]

Industry Medical - Devices

Sector Healthcare

IPO Date Jul 1, 2010

Employees 217

Stock Exchange AMEX

Ticker Symbol XTNT

Website https://www.xtantmedical.com

Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for XTNT stock is "Strong Buy." The 12-month stock price forecast is $3, which is an increase of 541.99% from the latest price.

Stock Forecasts

Next Earnings Release

Xtant Medical Inc. is scheduled to release its earnings on May 14, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

News

1 month ago · seekingalpha.com

Xtant Medical Holdings, Inc. (XTNT) Q4 2024 Earnings Call Transcript

Xtant Medical Holdings, Inc. (NYSE:XTNT ) Q4 2024 Results Conference Call March 6, 2025 4:30 PM ET Company Participants Brett Maas - Hayden IR Sean Browne - President & Chief Executive Officer Scott N...

1 month ago · accessnewswire.com

Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Full Year 2024 Revenue Growth of 28% Expects 2025 Revenue of $126 Million to $130 Million Without Need for Additional Capital BELGRADE, MT / ACCESS Newswire / March 6, 2025 / Xtant Medical Holdings, I...

2 months ago · accessnewswire.com

Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025

BELGRADE, MT / ACCESS Newswire / February 28, 2025 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal di...